Ignite Creation Date:
2025-12-24 @ 5:51 PM
Ignite Modification Date:
2026-01-02 @ 12:03 PM
Study NCT ID:
NCT00829868
Status:
COMPLETED
Last Update Posted:
2024-08-21
First Post:
2009-01-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Zaleplon 10 mg Capsules Under Non-Fasting Conditions
Sponsor:
Teva Pharmaceuticals USA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-02
Start Date Type:
None
Primary Completion Date:
2004-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-03
Completion Date Type:
ACTUAL
First Submit Date:
2009-01-26
First Submit QC Date:
None
Study First Post Date:
2009-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-07-06
Results First Submit QC Date:
None
Results First Post Date:
2009-08-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-19
Last Update Post Date:
2024-08-21
Last Update Post Date Type:
ACTUAL